Cargando…
Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis
PURPOSE: Amifostine is a highly efficacious cytoprotectant when administered in vivo at high doses. However, at elevated doses, drug toxicity manifests for general, non-clinical radioprotective purposes. Various strategies have been developed to avoid toxic side-effects: The simplest is reducing the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133974/ https://www.ncbi.nlm.nih.gov/pubmed/24597748 http://dx.doi.org/10.3109/09553002.2014.899450 |